Comparative Pharmacology
Head-to-head clinical analysis: OSMOLEX ER versus OXYBUTYNIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OSMOLEX ER versus OXYBUTYNIN.
OSMOLEX ER vs OXYBUTYNIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Trihexyphenidyl is a centrally acting anticholinergic agent that blocks muscarinic receptors in the striatum, helping to restore the balance between acetylcholine and dopamine in the basal ganglia, thereby reducing extrapyramidal symptoms.
Oxybutynin is an anticholinergic agent that competitively antagonizes muscarinic acetylcholine receptors (M1, M2, M3 subtypes) in the bladder detrusor muscle, inhibiting involuntary contractions and increasing bladder capacity.
Initial: 1 mg orally once daily; titrate by 1 mg every 3-5 days based on response and tolerability. Maximum: 8 mg once daily. Administer at bedtime.
5 mg orally 2-3 times daily; maximum 5 mg 4 times daily. Extended-release: 5-10 mg orally once daily; maximum 30 mg/day. Transdermal: 3.9 mg/day patch applied every 3-4 days. Topical gel: 1 g (3 pumps) applied once daily.
None Documented
None Documented
Clinical Note
moderateOxybutynin + Sulfisoxazole
"The metabolism of Sulfisoxazole can be decreased when combined with Oxybutynin."
Clinical Note
moderateOxybutynin + Erythromycin
"The metabolism of Erythromycin can be decreased when combined with Oxybutynin."
Clinical Note
moderateOxybutynin + Cyclosporine
"The metabolism of Cyclosporine can be decreased when combined with Oxybutynin."
Clinical Note
moderateOxybutynin + Fluconazole
Terminal elimination half-life is 5-8 hours in healthy adults; prolonged in renal impairment (up to 16 hours in severe impairment).
Terminal half-life: 12-13 hours (range 7-20 hours) in healthy adults. In elderly, half-life may be prolonged due to reduced clearance.
Primarily renal (60-80% as unchanged drug and glucuronide conjugates), biliary/fecal (20-40%)
Primarily hepatic metabolism; less than 1% excreted unchanged in urine. Metabolites are mainly excreted renally (50%) and fecally (40%).
Category C
Category A/B
Anticholinergic/Urinary Antispasmodic
Anticholinergic
"The metabolism of Fluconazole can be decreased when combined with Oxybutynin."